SCHEMBL10137585

SCHEMBL10137585

Cc1ccc(S(=O)(=O)c2cc(OCCC(C)C)cc(C(=O)OCc3ccccc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 3/20 0.43
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
CTRC Q99895 1/20 0.39
MCL1 Q07820 2/20 0.39
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
ADAM17 P78536 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10169583 0.83 MAPT (0.46) MAPTL3MBTL1LMNAPOLBRAB9A
SCHEMBL419486 0.79 KMT2A (0.47) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL6539253 0.76 MAPK1 (0.62) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL20168976 0.75 MAPT (0.68) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL9454243 0.71 KMT2A (0.59) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL16897964 0.69 KMT2A (0.73) MAPTLMNASLC6A2SLC6A3KMT2A
SCHEMBL6851170 0.69 KMT2A (0.68) MAPTLMNASLC6A2SLC6A3KMT2A
Benzyl Benzoate SCHEMBL19206942 0.69 KMT2A (0.82) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL6057219 0.69 KMT2A (0.76) MAPTL3MBTL1LMNASLC6A2SLC6A3
SCHEMBL9658401 0.68 MAPT (0.57) MAPTL3MBTL1LMNASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS WISCONSIN ALUMNI RESEARCH FOUNDATION 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS DNPEP, PRKCSH, YWHAZ MAPT 1177/4885L3MBTL1 1494/4885LMNA 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.